Concepedia

Kelsey Satterly

KS

Statistics

Publications

2

Citations

55

H-Index

2

Active since

2019

Affiliations

Impel Neuropharma (United States)(Current)

Kelsey Satterly is an author at Impel Neuropharma (United States).

Publications per year

2019–2020

2

Publications

2

STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD <sup>®</sup> ) Device, in Healthy Adult Subjects

Stephen B. Shrewsbury, Maria Jeleva, Kelsey Satterly et al. · Headache The Journal of Head and Face Pain · 2019 · 34 citations · Full text

The SNAP 101 Double-Blind, Placebo/Active-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of INP105 (Nasal Olanzapine) in Healthy Adults

Stephen B. Shrewsbury, Jasna Hocevar‐Trnka, Kelsey Satterly et al. · The Journal of Clinical Psychiatry · 2020 · 21 citations · Full text

1–2 of 2